Arca
Skip to content
Tools
Tools

ReAlta Life Sciences, Inc.

7 private offerings reported to the SEC on Form D since 2016, $94.3M sold in all. Biotech, Virginia.

  • Form D offerings: 7
  • Reported sold: $94.3M
  • Newest: May 21, 2025
  • FDA records: Company page

Every Form D offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
May 21, 2025—$29.9M$30.0MReAlta Life Sciences, Inc.Biotech · VirginiaNot amended0001752530-25-000002
May 21, 2025—$25.0M$25.0MReAlta Life Sciences, Inc.Biotech · VirginiaNot amended0001752530-25-000003
May 21, 2025—$12.0M$12.0MReAlta Life Sciences, Inc.Biotech · VirginiaNot amended0001752530-25-000001
Sep 13, 2023—$22.5M$22.5MReAlta Life Sciences, Inc.Biotech · VirginiaNot amended0001752530-23-000002
Feb 19, 2020—None yet$2.0MReAlta Life Sciences, Inc.Pharma · VirginiaNot amended0001752530-20-000001
Oct 28, 2019—None yet$12.0MReAlta Life Sciences, Inc.Pharma · VirginiaNot amended0001752530-19-000001
Sep 12, 2018—$4.8M$12.0MReAlta Life Sciences, Inc.Pharma · VirginiaNot amended0001752530-18-000001

SEC Profile

From the company's EDGAR record
Business address
Norfolk, Va
Incorporated in
Delaware
All SEC filings
CIK 1752530 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.